Yasushi Kohno

This inventor holds 21 USPTO granted patents and 5 published patent applications, plus 4 CIPO patents and 10 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Kyorin Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd.. Active years: 1992-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasushi Kohno. Retrieved from https://idiyas.com/inventor/yasushi-kohno-g3gdzoyk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 21 (Patent Applications = 5)

% Patents Active = 33.3

CIPO Patents = 4

EPO Patents = 10 (Patent Applications = 5)

Average Co-Inventor Count = 4.2

ph-index = 7

Forward Citations = 120(Granted Patents)

Location History:

Oyama, JP (1992 - 2010)
Shimotsuga-gun, JP (2011 - 2014)
Nogi, JP (2014)
Tochigi, JP (2005 - 2015)

Company Filing History:

21 out of 185

Kyorin Pharmaceutical Co., Ltd.

patents

2 out of 176

Kissei Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1992-2015

Loading Chart...

Areas of Expertise:

Diphenyl Sulfide Derivative

Spirocyclic Aminoquinolones

Indole Derivative

Amino Alcohol Derivative

S1P Receptor Modulator

GSK-3 Inhibitors

Immunosuppressive Agent

Aminophosphonic Acid Derivative

PDE Inhibitors

Diaryl Ether Derivative

Cyclic Anthranilic Acid Derivatives

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8993543 - Diphenyl sulfide derivative and pharmaceutical product which contains same as active ingredient (2015-03-31),

2. 8901112 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2014-12-02),

3. 8815903 - Indole derivative and pharmacologically acceptable salt thereof (2014-08-26),

4. 8796247 - Indole derivative, and pharmacologically acceptable salt thereof (2014-08-05),

5. 8569270 - Diphenyl sulfide derivatives and medicines containing same as active ingredient (2013-10-29),

6. 8476261 - Spirocyclic aminoquinolones as GSK-3 inhibitors (2013-07-02),

7. 8273748 - Amino alcohol derivative and immunosuppresive agent having same as an active ingredient (2012-09-25),

8. 8232319 - Amino phosphate derivative and S1P receptor modulator having same as an active ingredient (2012-07-31),

9. 8071591 - 7-cycloalkylaminoquinolones as GSK-3 inhibitors (2011-12-06),

10. 7879846 - Serine hydrolase inhibitors (2011-02-01),

11. 7763752 - Amino alcohol derivatives, salts thereof and immunosuppresive agents (2010-07-27),

12. 7763617 - Pyrazolopyridine-4-yl pyridazinone derivatives and addition salts thereof, and PDE inhibitors comprising the same derivatives or salts as active ingredient (2010-07-27),

13. 7759326 - Aminophosphonic acid derivative, salt thereof, and modulator of S1P receptor (2010-07-20),

14. 7482491 - Amino alcohol derivative, addition salt thereof, and immunosuppressant (2009-01-27),

15. 7456157 - Aminophosphonic acid derivatives, addition salts thereof and S1P receptor modulators (2008-11-25),

Title: **Yasushi Kohno: A Renowned Innovator in Pharmaceutical Patents**

Introduction

Yasushi Kohno, based in Tochigi, Japan, is an esteemed inventor with a commendable portfolio consisting of 21 patents. His work primarily focuses on the development of innovative pharmaceutical compounds that play a crucial role in treating various medical conditions. Kohno's contribution to the field of pharmaceuticals has paved the way for advancements in the mechanisms of drug action.

Latest Patents

Among Yasushi Kohno's most notable patents is the development of a diphenyl sulfide derivative, which serves as an active ingredient in pharmaceutical products. This innovative compound is recognized for its excellent S1P3 antagonist activity, which is essential for addressing specific therapeutic needs. The general formula (1) of the diphenyl sulfide derivative involves an alkoxy group with 1-6 carbon atoms, a propyl or allyl group, and includes various elemental modifications.

Additionally, Kohno has contributed to the advancement of spirocyclic aminoquinolones as GSK-3 inhibitors. The spirocyclic aminoquinolones detailed in his patents show potential in the prevention and treatment of diseases mediated by GSK-3 inhibitors. These discoveries reflect his extensive research and dedication to finding effective therapeutic solutions.

Career Highlights

Yasushi Kohno has had a successful career working with prominent pharmaceutical companies, including Kyorin Pharmaceutical Co., Ltd. and Kissei Pharmaceutical Co., Ltd. His innovative contributions have established him as a leading figure in the pharmaceutical industry, recognized for pioneering new compounds that aid in combating complex diseases.

Collaborations

Throughout his career, Kohno has collaborated with notable colleagues, such as Kazuhiko Kuriyama and Kiyoaki Tanaka. These partnerships have propelled his research initiatives forward, resulting in impactful innovations in pharmaceutical development.

Conclusion

Yasushi Kohno’s work exemplifies the spirit of innovation in pharmaceutical research. With a strong foundation of patents and rich collaborative efforts, he continues to contribute significantly to the medical field. His advancements in drug development promise to enhance treatment options, ultimately improving patient outcomes around the globe.

Profile summary based on public USPTO records.